Drugs / Protopic ointment 0.1%
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03614221 | Jun 2019 → Dec 2021 | atopic eczema | Chang Gung Memorial Hospital | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Protopic ointment 0.1% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03614221 ↗ |
| Known as | Protopic | “Comparison of the Efficacy and Safety of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® (Tacrolimus 0.1%) Ointment in Treating Atopic Dermatitis: A Randomized,...” NCT03614221 ↗ |
| Action | Inhibit | “calcineurin inhibitor (such as Tacrolimus)” NCT03614221 ↗ |
| Route | Topical | “Apply 0.1 g of ointment per 10 cm x 10 cm of affected skin areas twice daily for 6 weeks.” NCT03614221 ↗ |